SURPASS Wins CRO Leadership Awards for a Second Year in a Row
May 13, 2019
Preclinical Research Leader, SURPASS, Wins CRO Leadership Awards by Life Science Leader Magazine for a Second Year in a Row.
OSCEOLA, WI and MOUNTAIN VIEW, CA -—Surpass, Inc. ("Surpass"), a leading preclinical contract research organization (CRO) servicing the medical device, pharma, and biotech industries received CRO Leadership Awards by Life Science Leader Magazine for the second year in a row in the areas of quality and regulatory. The awards are based on feedback from customers who use preclinical CRO services and industry research conducted by Nice Insight.
"We are honored to be recognized again this year as a leading preclinical contract research organization with impeccable quality and regulatory compliance," said Surpass CEO, Dr. Tim Pelura. "These awards acknowledge Surpass' strong commitment to excellence and delivering robust preclinical data to our clients. As an active member of the medical innovation continuum, we bring more to our client partners, consistently delivering high quality translational data and innovative solutions to help our clients advance their technologies and therapies into the marketplace."
The CRO Leadership Awards were developed to assist life science executives and directors in their vetting process of CROs. The surveys and industry research for this award was managed by Nice Insight, the market research division of That's Nice LLC. Nice Insight surveyed more than 2300 decision makers who use CRO services. From the list of more than 70 CROs who were profiled, the top 10% from each category were recognized with CRO Leadership Awards (A list of the 2015 CRO Leadership Award winners can be found on the CRO Leadership Awards website).
View full press release on iReach/PRNewswire.
